Telix Pharmaceuticals Investors Encouraged to Join Securities Fraud Class Action Lawsuit Investors in Telix Pharmaceuticals are reminded of the January 2026 deadline to join a securities fraud class action lawsuit, seeking compensation.

Telix Pharmaceuticals Investors Encouraged to Join Securities Fraud Class Action Lawsuit #USA #New_York #Law_Firm #Telix_Pharmaceuticals #TLS_Securities